Flow Cytometry Market statistics and research analysis released in latest report

The report Flow Cytometry Market by Technology (Cell & Bead-based), Product & Services (Analyzer, Sorter, Reagents), Application (Research (Cell Analysis), Clinical (Cancer, HIV)), End User (Academia, Research Institute, Hospital) – Global Forecast to 2022″, The global flow cytometry market is expected to reach USD 4.79 Billion by 2022 from USD 3.29 Billion in 2017, at a CAGR of 7.8%.

Know more :- https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html

By technology, the global flow cytometry market is categorized into cell-based and bead-based flow cytometry. The bead-based technology segment is expected to grow at the highest CAGR during the forecast period, owing to the procedural advantages offered by this technology over other cell-based technology (enzyme-linked immunosorbent assay (ELISA) and western blot), such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.

On the basis of product and service, the flow cytometry market is categorized into reagents and consumables; instruments; services; software; and accessories. The reagents and consumables segment accounted for the largest share of the flow cytometry market in 2017. Factors such as the development and commercialization of high-quality application-specific reagents and assays and continuous requirement of flow cytometry reagents by end users are expected to drive the growth of the reagents and consumables market in the coming years.

Request for Sample of the Report : https://www.marketsandmarkets.com/requestsample.asp?id=65374584

By application, the global market is divided into research, clinical, and industrial applications. The clinical applications segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the growing usage of flow cytometry in organ transplantation, cancer diagnosis, and hematological disorder treatment.

By end user, the flow cytometry market is categorized into academic and research institutes, hospitals and clinical testing laboratories, and pharmaceutical and biotechnology companies.